Literature DB >> 17614975

Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?

A Gomes-Silva1, R de Cássia Bittar, R Dos Santos Nogueira, V S Amato, M da Silva Mattos, M P Oliveira-Neto, S G Coutinho, A M Da-Cruz.   

Abstract

Suitable levels of interferon (IFN)-gamma and interleukin (IL)-10 seem to favour the outcome of cutaneous leishmaniasis (CL), while high IFN-gamma and low IL-10 production are associated with severity of mucosal leishmaniasis (ML). Considering that cytokine balance is important for the maintenance of protective responses in leishmaniasis, our aim was to investigate leishmanial antigens-induced IFN-gamma and IL-10 levels maintained in healed individuals who had different clinical outcomes of Leishmania infection. Thirty-three individuals who recovered from L. braziliensis infection were studied: cured CL (CCL), cured ML (CML), spontaneous healing of CL (SH) or asymptomatic individuals (ASY). Cytokines were quantified by enzyme-linked immunosorbent assay (ELISA) in culture supernatants of L. braziliensis-stimulated peripheral blood mononuclear cells (PBMC). IFN-gamma levels were higher in CML (7593 +/- 5994 pg/ml) in comparison to SH (3163 +/- 1526 pg/ml), ASY (1313 +/- 1048 pg/ml) or CCL (1897 +/- 2087 pg/ml). Moreover, cured ML cases maintained significantly lower production of IL-10 (127 +/- 57.8 pg/ml) in comparison to SH (1373 +/- 244 pg/ml), ASY (734 +/- 233 pg/ml) or CCL (542 +/- 375 pg/ml). Thus, a high IFN-gamma/IL-10 ratio observed in CML can indicate unfavourable cytokine balance. On the other hand, no significant difference in the IFN-gamma/IL-10 ratio was observed when CCL individuals were compared to SH or ASY subjects. In conclusion, even after clinical healing, ML patients maintained a high IFN-gamma/IL-10 secretion profile in response to leishmanial antigens. This finding can explain a delayed down-modulation of exacerbated inflammatory responses, which can be related in turn to the necessity of prolonged therapy in ML management. Conversely, lower IFN-gamma/IL-10 balance observed in CCL, SH and ASY individuals can represent a better-modulated immune response associated with a favourable prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614975      PMCID: PMC2219325          DOI: 10.1111/j.1365-2249.2007.03436.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.

Authors:  E Bourreau; G Prévot; J Gardon; R Pradinaud; P Launois
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

2.  Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Authors:  R L Bottrel; W O Dutra; F A Martins; B Gontijo; E Carvalho; M Barral-Netto; A Barral; R P Almeida; W Mayrink; R Locksley; K J Gollob
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection.

Authors:  F Bosque; N G Saravia; L Valderrama; G Milon
Journal:  Scand J Immunol       Date:  2000-05       Impact factor: 3.487

5.  Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection.

Authors:  Ivonise Follador; Cibele Araújo; Olívia Bacellar; Clarissa B Araújo; Lucas P Carvalho; Roque P Almeida; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2002-05-07       Impact factor: 9.079

6.  T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.

Authors:  Alda Maria Da-Cruz; Rita Bittar; Marise Mattos; Manuel P Oliveira-Neto; Ricardo Nogueira; Vanessa Pinho-Ribeiro; Rilza Beatriz Azeredo-Coutinho; Sergio G Coutinho
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.

Authors:  Rita C Bittar; Ricardo S Nogueira; Ricardo Vieira-Gonçalves; Vanessa Pinho-Ribeiro; Marise S Mattos; Manoel Paes Oliveira-Neto; Sergio G Coutinho; Alda M Da-Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2007-08       Impact factor: 2.743

Review 8.  Development and regulation of cell-mediated immunity in experimental leishmaniasis.

Authors:  Phillip Scott
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 9.  Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection.

Authors:  G Trinchieri
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

10.  The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

Authors:  Y Belkaid; K F Hoffmann; S Mendez; S Kamhawi; M C Udey; T A Wynn; D L Sacks
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  38 in total

1.  Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil.

Authors:  Maria Zilma Andrade Rodrigues; Maria Fernanda Rios Grassi; Sanjay Mehta; Xing-Quan Zhang; Luana Leandro Gois; Robert T Schooley; Roberto Badaro
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

Authors:  T S L Keesen; L R V Antonelli; D R Faria; L H Guimarães; O Bacellar; E M Carvalho; W O Dutra; K J Gollob
Journal:  Clin Exp Immunol       Date:  2011-07-04       Impact factor: 4.330

3.  Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

Review 4.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

5.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

6.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

7.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

Review 8.  Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology.

Authors:  Kenneth J Gollob; Lis R V Antonelli; Daniela R Faria; Tatjana S L Keesen; Walderez O Dutra
Journal:  Int Immunopharmacol       Date:  2008-10       Impact factor: 4.932

9.  Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology.

Authors:  Walderez O Dutra; Daniela Rodrigues de Faria; Paulo Roberto Lima Machado; Luiz Henrique Guimarães; Albert Schriefer; Edgar Carvalho; Kenneth J Gollob
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

10.  Comparative evaluation of lesion development, tissue damage, and cytokine expression in golden hamsters (Mesocricetus auratus) infected by inocula with different Leishmania (Viannia) braziliensis concentrations.

Authors:  Raquel P Ribeiro-Romão; Otacílio C Moreira; Elvia Yaneth Osorio; Lea Cysne-Finkelstein; Adriano Gomes-Silva; Joanna G Valverde; Claude Pirmez; Alda Maria Da-Cruz; Eduardo Fonseca Pinto
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.